Partner Nate Lacktman is quoted in a South Florida Business Journal article, “South Florida hospitals embrace telemedicine,” about the prospects for passage of a law that would cover telemedicine services in the state.
Lacktman said Florida is one of only 18 states that does not have a telehealth commercial insurance law, although that may change with next year’s legislative session, which will include a review of a report that touts the benefits of telemedicine and outlines the benefits of requiring additional coverage for the service.
“The report shows there’s widespread enthusiasm in telemedicine, and Florida is uniquely poised to take advantage of the power that technology offers,” he said.
Lacktman said Florida is one of only 18 states that does not have a telehealth commercial insurance law, although that may change with next year’s legislative session, which will include a review of a report that touts the benefits of telemedicine and outlines the benefits of requiring additional coverage for the service.
“The report shows there’s widespread enthusiasm in telemedicine, and Florida is uniquely poised to take advantage of the power that technology offers,” he said.
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”